fbpx
ESKETAMINE: ONE STEP CLOSER TO FDA APPROVAL

ESKETAMINE: ONE STEP CLOSER TO FDA APPROVAL

In August 2016, Janssen Research & Development—a Janssen Pharmaceutical Company of Johnson & Johnson—announced that an isomer of ketamine, called esketamine, had received Breakthrough Therapy Designation by the Food & Drug Administration (FDA). Similarly...
THE CASE FOR KETAMINE: 2017 IN REVIEW

THE CASE FOR KETAMINE: 2017 IN REVIEW

Researchers first discovered the antidepressant effects of ketamine back in 2000, and have since come to recognize the drug’s ability to improve depressive symptoms—even in patients who had not responded to other methods of treatment—in a matter of hours. Private...